Anti-GAD associated post-infectious cerebellitis after COVID-19 infection

Emekli A. S., Parlak A., Gocen N. Y., Kurtuncu M.

NEUROLOGICAL SCIENCES, cilt.42, sa.10, ss.3995-4002, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 42 Sayı: 10
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1007/s10072-021-05506-6
  • Dergi Adı: NEUROLOGICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CINAHL, EMBASE, Index Islamicus, MEDLINE, Psycinfo
  • Sayfa Sayıları: ss.3995-4002
  • Anahtar Kelimeler: Ataxia, Anti-GAD, COVID-19, SARS-CoV-2, Post-infectious, Cerebellitis, NMDA RECEPTOR ENCEPHALITIS, ATAXIA
  • İstanbul Üniversitesi Adresli: Evet

Özet

The coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread rapidly all over the world. Besides severe pneumonia, it causes multisystemic disease, including neurological findings. Here, we present a patient with anti-glutamic acid decarboxylase (anti-GAD) antibody-associated cerebellitis developed after COVID-19 infection. The patient responded well to the immune treatments. Our knowledge about SARS-CoV-2 infection-related neurological disorders is limited. New data are needed to recognize the clinical spectrum of autoimmune neurological disorders that emerges after SARS-CoV-2 infection.